Nona Biosciences Collaboration Partner Pfizer Announces Presentation of Phase 1 Clinical Study Design on MesoC2, an MSLN-Targeting ADC, at the 2025 ASCO Annual Meeting ...

This non-comparative1 pilot study, including patients with Prosthetic Joint Infections (PJI), recruited 29 patients, 26 of whom were evaluable for clinical activity, out of the 64 initially ...

Parkinson's disease (PD) affects more than 6 million people worldwide, yet the gold-standard treatment was approved over 30 ...

We reviewed the structural domains and items in trial design and conduct and discussed the strengths and limitations of DEEC studies, aiming to enhance the utilization of this trial design to generate ...

In an observational extension of the myPACE clinical trial, researchers found that a personalized accelerated pacing in ...

Victorian brain cancer researchers have achieved a global-first, using an innovative process to learn how a new drug ...

Building Reliable and Compliant Technical Systems What stands out as one reflects on Pralohith's journey is the increasing ...

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc., in collaboration with Asher ...

Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie is currently conducting a Phase 1 clinical study ...

We read with great interest the article by Adams et al in * Gut * on the development and validation of the Admission Model for Intensification of Therapy in Acute Severe Colitis (ADMIT-ASC) score to ...